OptimizeRx Corp. (OPRX)

9.85
0.28 2.80
NASDAQ : Technology Services
Prev Close 10.13
Open 10.29
Day Low/High 9.78 / 10.29
52 Wk Low/High 8.92 / 17.24
Volume 82.54K
Avg Volume 116.20K
Exchange NASDAQ
Shares Outstanding 14.54M
Market Cap 148.54M
P/E Ratio N/A
Div & Yield N.A. (N.A)

OptimizeRx Reports First Quarter 2017 Results

Q1 2017 Net Revenue up 22% to $2.2 Million

OptimizeRx Corporation Reports Record Fourth Quarter And Full Year 2016 Results

Fourth Quarter Drives Net Revenue Up 7% to $7.8 Million in 2016

OptimizeRx Integrates With Eye Care Leaders To Deliver Improved Eye Care And Cost Savings On Prescriptions

OptimizeRx Integrates With Eye Care Leaders To Deliver Improved Eye Care And Cost Savings On Prescriptions

OptimizeRx's Digital Health Platform to Integrate with Eye Care Leaders' EHRs Accessible to 6,800 Ophthalmologists and Optometrists Nationwide

OptimizeRx Corporation Reports Third Quarter 2016 Results

OptimizeRx Corporation Reports Third Quarter 2016 Results

Rebranding, Expanded Allscripts Partnership, and Investments in Sales Team Support Growth in Q4 and into 2017

OptimizeRx's Promotional Programs Deliver Return On Investment Of Up To 12:1 ROI

OptimizeRx's Promotional Programs Deliver Return On Investment Of Up To 12:1 ROI

Proven as One of the Most Effective Digital Tactics Available to Pharmaceutical Manufacturers

OptimizeRx Corporation Reports Second Quarter 2016 Results

OptimizeRx Corporation Reports Second Quarter 2016 Results

Net Revenue up 12% to $1.9 Million in Q2 2016, Driven by Increased Promotion of Pharmaceutical Brands and Expanded Distribution Channels

OptimizeRx Corporation Reports First Quarter 2016 Results

OptimizeRx Corporation Reports First Quarter 2016 Results

Core Promotional Transactions Up 16%, Driving Q1 Net Revenue up 18% to $1.8 Million

TheStreet Quant Rating: C (Hold)